Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Manjiri, Pawaskar"'
Autor:
Norberto Giglio, Pieralessandro Lasalvia, Manjiri Pawaskar, Cintia I. Parellada, Diego Rosselli, Virginia V. Babic, Silvina E. Neyro
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
Since the introduction of Universal Varicella Vaccination (UVV) in the Argentinean National Immunization Program in 2015, a significant decline in the incidence of varicella has been reported. This study aimed to estimate the economic impact of singl
Externí odkaz:
https://doaj.org/article/c9ced68f4e104eff8dfd1a5bba0c0d1d
Autor:
Boshu Ru, Stephanie Kujawski, Nelson Lee Afanador, Richard Baumgartner, Manjiri Pawaskar, Amar Das
Publikováno v:
JMIR Formative Research, Vol 7, p e42832 (2023)
BackgroundMeasles, a highly contagious viral infection, is resurging in the United States, driven by international importation and declining domestic vaccination coverage. Despite this resurgence, measles outbreaks are still rare events that are diff
Externí odkaz:
https://doaj.org/article/478e26f8b9e84e7cb1ea8b808f72d182
Autor:
Manjiri Pawaskar, Elvira Schmidt, Gary S. Marshall, Jaime Fergie, Elizabeth Richardson, Louise Parks Saldutti, Se Li, Monika Neumann, Linnea Koller, Barbara Kuter
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-7 (2022)
M-M-R®II (M-M-R II) is routinely used in many countries at 12–15 months with a second dose at 4 to 6 years of age. However, the vaccine may need to be administered at other ages due to delays in the immunization schedule or in certain situations s
Externí odkaz:
https://doaj.org/article/92e3bb86aa0e48e0b44dd8ccc515fd4b
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 9, p e0002407 (2023)
[This corrects the article DOI: 10.1371/journal.pgph.0001743.].
Externí odkaz:
https://doaj.org/article/bde37ba70d114ef483d08582469efd84
Publikováno v:
PLoS ONE, Vol 18, Iss 4, p e0283465 (2023)
BackgroundVaricella is usually a mild disease in children but may be life-threatening, especially in adolescents and adults. Infection control measures implemented during the Coronavirus Disease 2019 (COVID-19) pandemic may have suppressed varicella
Externí odkaz:
https://doaj.org/article/f2b61ce57c9f42e78e095c6fc7efe182
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 4, p e0001743 (2023)
We modeled the long-term clinical and economic impact of two-dose universal varicella vaccination (UVV) strategies in Denmark using a dynamic transmission model. The cost-effectiveness of UVV was evaluated along with the impact on varicella (includin
Externí odkaz:
https://doaj.org/article/b54de86cd13c490b8d8510a8d496b820
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 12, Pp 5372-5383 (2021)
Measles, mumps, and rubella are highly contagious diseases that caused significant global mortality and morbidity in the pre-vaccine era. Since its first approval in the United States over 40 years ago, M-M-RII has been used in >75 countries for prev
Externí odkaz:
https://doaj.org/article/473b2aeb5eda4239a05f3572132c99ca
Autor:
Manjiri Pawaskar, Estelle Méroc, Salome Samant, Elmira Flem, Goran Bencina, Margarita Riera-Montes, Ulrich Heininger
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Though the disease burden of varicella in Europe has been reported previously, the economic burden is still unknown. This study estimated the economic burden of varicella in Europe in the absence of Universal Varicella Vaccination
Externí odkaz:
https://doaj.org/article/8bc2f2e9dce04b4aab7cfb117fa0ffd6
Autor:
Jessica Vandenhaute, Elyonore Tsakeu, Pierre Chevalier, Manjiri Pawaskar, Goran Benčina, Jan Vertriest
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Varicella is a highly contagious infection that typically occurs in childhood. While most cases have a generally benign outcome, infection results in a considerable healthcare burden and serious complications may occur. Objectives
Externí odkaz:
https://doaj.org/article/7d3e93f988ad41ceaf1564b6652b4f06
Autor:
Stephanie A. Kujawski, Colleen Burgess, Oren Agi, Zohar Attias-Geva, Matthew Pillsbury, David Greenberg, Goran Bencina, Manjiri Pawaskar
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Currently available health economic models for varicella infection are designed to inform the cost-effectiveness of universal varicella vaccination (UVV) compared with no vaccination. However, in countries with an existing UVV program, these models c
Externí odkaz:
https://doaj.org/article/1ec9dd97e1f34a928819c89d73e7c5e3